Boston Scientific Current Ratio 2010-2025 | BSX

Current and historical current ratio for Boston Scientific (BSX) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Boston Scientific current ratio for the three months ending March 31, 2025 was 1.45.
Boston Scientific Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $7.34B $5.06B 1.45
2024-12-31 $6.92B $6.40B 1.08
2024-09-30 $8.76B $5.91B 1.48
2024-06-30 $8.99B $5.58B 1.61
2024-03-31 $8.19B $4.92B 1.67
2023-12-31 $6.51B $4.93B 1.32
2023-09-30 $6.50B $4.58B 1.42
2023-06-30 $5.89B $4.56B 1.29
2023-03-31 $5.70B $4.08B 1.40
2022-12-31 $5.76B $3.80B 1.52
2022-09-30 $5.14B $3.55B 1.45
2022-06-30 $5.08B $3.88B 1.31
2022-03-31 $5.07B $4.28B 1.19
2021-12-31 $6.32B $4.27B 1.48
2021-09-30 $6.23B $4.02B 1.55
2021-06-30 $6.76B $4.07B 1.66
2021-03-31 $6.10B $3.39B 1.80
2020-12-31 $6.69B $3.68B 1.82
2020-09-30 $6.16B $3.30B 1.87
2020-06-30 $5.80B $3.11B 1.87
2020-03-31 $4.82B $3.98B 1.21
2019-12-31 $4.70B $4.87B 0.97
2019-09-30 $4.85B $4.25B 1.14
2019-06-30 $6.33B $4.85B 1.31
2019-03-31 $6.23B $4.48B 1.39
2018-12-31 $4.00B $5.26B 0.76
2018-09-30 $3.97B $5.08B 0.78
2018-06-30 $3.93B $4.75B 0.83
2018-03-31 $4.08B $4.99B 0.82
2017-12-31 $3.82B $5.65B 0.68
2017-09-30 $3.48B $4.83B 0.72
2017-06-30 $3.22B $4.30B 0.75
2017-03-31 $3.03B $3.49B 0.87
2016-12-31 $3.24B $3.59B 0.90
2016-09-30 $3.18B $3.02B 1.06
2016-06-30 $3.33B $3.18B 1.05
2016-03-31 $3.16B $2.61B 1.21
2015-12-31 $3.47B $2.43B 1.43
2015-09-30 $3.46B $2.24B 1.55
2015-06-30 $3.77B $1.94B 1.95
2015-03-31 $3.19B $2.46B 1.30
2014-12-31 $3.61B $2.85B 1.27
2014-09-30 $3.18B $1.82B 1.75
2014-06-30 $3.21B $1.77B 1.81
2014-03-31 $2.94B $1.72B 1.71
2013-12-31 $3.01B $1.82B 1.65
2013-09-30 $3.53B $1.90B 1.85
2013-06-30 $3.50B $2.48B 1.41
2013-03-31 $3.10B $1.64B 1.90
2012-12-31 $3.02B $1.77B 1.71
2012-09-30 $3.17B $1.82B 1.75
2012-06-30 $3.11B $1.79B 1.73
2012-03-31 $3.09B $1.67B 1.85
2011-12-31 $3.11B $1.81B 1.72
2011-09-30 $3.21B $1.89B 1.70
2011-06-30 $3.15B $1.89B 1.66
2011-03-31 $3.57B $2.04B 1.75
2010-12-31 $3.62B $2.61B 1.39
2010-09-30 $3.56B $2.96B 1.20
2010-06-30 $3.99B $3.72B 1.07
2010-03-31 $3.75B $2.91B 1.29
2009-12-31 $4.60B $3.02B 1.52
2009-09-30 $4.96B $3.18B 1.56
2009-06-30 $4.80B $2.75B 1.74
2009-03-31 $4.57B $2.43B 1.88
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $152.531B $16.747B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.634B 27.97
Stryker (SYK) United States $145.427B 30.41
EssilorLuxottica (ESLOY) France $127.535B 0.00
Medtronic (MDT) Ireland $109.709B 15.55
Haleon (HLN) United Kingdom $49.754B 28.33
Lonza Group Ag (LZAGY) Switzerland $49.468B 0.00
ResMed (RMD) United States $36.224B 27.21
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Agilent Technologies (A) United States $32.148B 20.88
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.748B 89.29
Koninklijke Philips (PHG) Netherlands $21.431B 15.40
Zimmer Biomet Holdings (ZBH) United States $18.172B 11.67
Baxter (BAX) United States $15.441B 11.53
Smith & Nephew SNATS (SNN) United Kingdom $12.754B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.002B 20.89
Lantheus Holdings (LNTH) United States $5.375B 13.56
Prestige Consumer Healthcare (PBH) United States $4.194B 18.74
Perrigo (PRGO) Ireland $3.646B 9.24
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.213B 23.69
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.048B 14.09
LeMaitre Vascular (LMAT) United States $1.872B 41.85
AtriCure (ATRC) United States $1.719B 0.00
Neogen (NEOG) United States $1.302B 16.67
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.110B 24.97
BioLife Solutions (BLFS) United States $1.016B 0.00
Kestra Medical Technologies (KMTS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.986B 12.60
InMode (INMD) Israel $0.930B 9.37
Evolus (EOLS) United States $0.642B 0.00
CeriBell (CBLL) United States $0.612B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Curaleaf Holdings (CURLF) Canada $0.544B 0.00
Valneva SE (VALN) France $0.519B 0.00
Owens & Minor (OMI) United States $0.517B 4.29
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Surmodics (SRDX) United States $0.422B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.326B 11.98
Aurora Cannabis (ACB) Canada $0.302B 53.70
Cresco Labs (CRLBF) United States $0.277B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.63
Sanara MedTech (SMTI) United States $0.259B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanuwave Health (SNWV) United States $0.242B 0.00
Canopy Growth (CGC) Canada $0.222B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Verano Holdings (VRNOF) United States $0.216B 0.00
Quanterix (QTRX) United States $0.211B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Biote (BTMD) United States $0.194B 5.46
Brainsway (BWAY) Israel $0.192B 50.95
High Tide (HITI) Canada $0.185B 0.00
Omeros (OMER) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.81
Organigram Global (OGI) Canada $0.178B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.135B 16.58
Jin Medical (ZJYL) China $0.122B 0.00
TerrAscend (TSNDF) Canada $0.098B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Veru (VERU) United States $0.090B 0.00
Fonar (FONR) United States $0.090B 11.62
Agape ATP (ATPC) $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
InterCure (INCR) Israel $0.070B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.037B 12.94
Nephros (NEPH) United States $0.035B 46.71
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00